Predictive Oncology Net Income
| POAIDelisted Stock | USD 5.95 0.00 0.00% |
As of the 12th of February 2026, Predictive Oncology holds the Coefficient Of Variation of (6,706), variance of 62.05, and insignificant Risk Adjusted Performance. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Predictive Oncology, as well as the relationship between them.
Predictive Oncology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Predictive Oncology's valuation are provided below:Predictive Oncology does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Predictive |
Search Suggestions
| POWWP | Ammo Preferred | Company |
| POM | POMDOCTOR LIMITED American | Company |
| POAAX | Pacific Funds Portfolio | Mutual Fund |
| POW | Tidal Trust III | ETF |
| POL | Polygon Ecosystem Token | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Predictive Oncology reported net income of (10.86 Million). This is 103.18% lower than that of the Health Care Equipment & Supplies sector and 110.9% lower than that of the Health Care industry. The net income for all United States stocks is 101.9% higher than that of the company.
Predictive Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Predictive Oncology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics of similar companies.Predictive Oncology is currently under evaluation in net income category among its peers.
Predictive Fundamentals
| Return On Equity | -7.46 | |||
| Return On Asset | -1.29 | |||
| Operating Margin | (906.54) % | |||
| Current Valuation | 21.66 M | |||
| Shares Outstanding | 3.39 M | |||
| Shares Owned By Insiders | 4.92 % | |||
| Shares Owned By Institutions | 0.15 % | |||
| Number Of Shares Shorted | 68.79 K | |||
| Price To Book | 1.43 X | |||
| Price To Sales | 12.07 X | |||
| Revenue | 1.62 M | |||
| Gross Profit | 814.04 K | |||
| EBITDA | (10.24 M) | |||
| Net Income | (10.86 M) | |||
| Cash And Equivalents | 25.39 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.13 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 7.74 X | |||
| Book Value Per Share | (100.94) X | |||
| Cash Flow From Operations | (11.96 M) | |||
| Short Ratio | 2.30 X | |||
| Earnings Per Share | (141.32) X | |||
| Target Price | 3.0 | |||
| Number Of Employees | 23 | |||
| Beta | 1.35 | |||
| Market Capitalization | 20.09 M | |||
| Total Asset | 4.97 M | |||
| Retained Earnings | (180.43 M) | |||
| Working Capital | (1.37 M) | |||
| Net Asset | 4.97 M |
About Predictive Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Predictive Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Predictive Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Predictive Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Predictive Stock
If you are still planning to invest in Predictive Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Predictive Oncology's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |